Can Addphos Be Given Through a Feeding Jejunostomy?
No, Addphos (sodium phosphates injection) should NOT be administered through a feeding jejunostomy tube—it is formulated exclusively for intravenous use after dilution and must never be given via enteral routes.
Critical Safety Information
The FDA labeling for Addphos explicitly states it is "administered intravenously only after dilution and thorough mixing in a larger volume of fluid" and "must not be administered undiluted" 1. This is an intravenous electrolyte replenisher, not an enteral supplement.
Why This Matters for Patient Safety
- Route-specific formulation: Addphos is a concentrated sterile solution (3 mM P/mL) designed for IV administration in TPN or other IV fluids 1
- Osmolarity concerns: The solution has an osmolar concentration of 7 mOsmol/mL, which is inappropriate for direct jejunal administration
- pH incompatibility: With a pH of 5.0-6.0, this acidic solution could cause mucosal injury if administered enterally 1
Common Pitfall to Avoid
Do not confuse Addphos (sodium phosphates injection) with calcium carbonate. The question mentions "calcium carbonate (Addphos)" but this is incorrect—Addphos contains sodium phosphates, not calcium carbonate. These are entirely different compounds with different indications and routes of administration.
Practical Guidance for Jejunostomy Tubes
If you need to provide phosphorus or calcium supplementation to a patient with a jejunostomy tube:
- For medications through jejunostomy: Guidelines emphasize that when using gastrojejunostomy tubes, medications should be administered through the larger diameter gastric port when possible to prevent tube clogging 2
- Tube occlusion risk: Jejunal extension tubes (8-12 F) have high occlusion rates (3.5%-35%), making them unsuitable for concentrated or particulate medications 2
- Alternative supplementation: Use appropriate oral/enteral formulations of phosphorus or calcium designed for enteral administration, not IV preparations
Key Takeaway
Addphos is strictly an IV medication that requires dilution before administration through central or peripheral venous access. Never attempt to administer IV formulations through feeding tubes, as this represents both a medication error and a significant patient safety risk.